Treatment and prevention of alcoholic liver disease
AssigneeBoehringer Ingelheim International GmbH
InventorsHerbert Tilg, Maria Effenberger
Life of this patent
Estimating the term…
Abstract
Methods of treating or preventing alcoholic liver disease are disclosed, the methods comprising administering to a subject a therapeutically or prophylactically effective amount of an agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling.
Claims27
An agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling for use in a method of treating or preventing alcoholic liver disease.
Use of an agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling in the manufacture of a medicament for use in a method of treating or preventing alcoholic liver disease.
A method of treating or preventing alcoholic liver disease, comprising administering a therapeutically or prophylactically effective amount of an agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling to a subject.
Dependencies are inferred from the claim text.